1. Home
  2. CATY vs CNTA Comparison

CATY vs CNTA Comparison

Compare CATY & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cathay General Bancorp

CATY

Cathay General Bancorp

HOLD

Current Price

$54.48

Market Cap

3.4B

Sector

Finance

ML Signal

HOLD

Logo Centessa Pharmaceuticals plc

CNTA

Centessa Pharmaceuticals plc

HOLD

Current Price

$39.52

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CATY
CNTA
Founded
1962
2020
Country
United States
United Kingdom
Employees
N/A
118
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
6.1B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
CATY
CNTA
Price
$54.48
$39.52
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$52.75
$42.00
AVG Volume (30 Days)
305.8K
5.0M
Earning Date
04-22-2026
05-13-2026
Dividend Yield
2.80%
N/A
EPS Growth
14.94
29.13
EPS
4.54
N/A
Revenue
$53,793,000.00
$15,000,000.00
Revenue This Year
$20.37
N/A
Revenue Next Year
$5.41
N/A
P/E Ratio
$11.96
N/A
Revenue Growth
2.93
N/A
52 Week Low
$39.36
$10.95
52 Week High
$55.09
$40.26

Technical Indicators

Market Signals
Indicator
CATY
CNTA
Relative Strength Index (RSI) 70.44 74.75
Support Level $46.90 $39.16
Resistance Level $54.64 $40.26
Average True Range (ATR) 1.09 0.32
MACD 0.32 -0.10
Stochastic Oscillator 90.00 34.09

Price Performance

Historical Comparison
CATY
CNTA

About CATY Cathay General Bancorp

Cathay General Bancorp is a regional bank predominantly serving the Chinese-American community. The company's policy is to reach out and actively offer services to low-to-moderate income groups in the delineated branch service areas. It predominantly provides services such as checking and deposit, lines of credits, commercial and commercial real estate loans, merchant services and payment processing, treasury management services, international banking and financing services, and other customary banking services to individuals, professionals, and small to medium-sized businesses. Through its Wealth Management unit, the company also offers investment products and services, such as stocks, bonds, mutual funds, insurance, annuities and advisory services.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.

Share on Social Networks: